A. A Northern blot with 10 μg total RNA from Aplysia pleural ganglia loaded in each lane, after treatment with either 2′-O-methyl oligonucleotides antisense to miR-124 conjugated to penetratin, or with 2′-O-methyl control oligonucleotides antisense to miR-194, or with vehicle alone. Blots are probed for miR-124 to show efficient and specific knockdown of miR-124 by penetratin conjugates. Blots were re-probed to detect tRNA, without stripping, to verify equal loading of all lanes. Level of knockdown is quantified by taking the mean % reduction of antisense miR-124 as compared to antisense miR-194 over 4 independent trials ± S.D.
B. A Western blot loaded with 15 μg total protein in each lane, after treatment with either 2′-O-methyl oligonucleotides antisense to miR-124 conjugated to penetratin, or with 2′-O-methyl control oligonucleotides antisense to miR-194, or with vehicle alone. CREB1, and three of its downstream targets, kinesin heavy chain (KHC), CAAT enhancer binding protein (C/EBP), and ubiquitin C-terminal hydrolase (UCH) are up-regulated after miR-124 inhibition. CREB2 and MAPK are not altered by miR-124. All blots were re-probed with beta tubulin, to verify equal loading of all lanes. Changes in protein levels were quantified as a ratio of band intensity between anti-miR-124 and control oligo treatment, after each was normalized to the loading control. Data is shown as a mean of 10 independent trials for CREB1 and at least 5 for all others ± S.D.
C. The miR-124 target site in the Aplysia CREB1 UTR is shown, along with the constructs used for the following reporter assay. A luciferase reporter (100ng) bearing the CREB UTR (full CREB UTR) is repressed by 45% when co-transfected with miR-124 duplex (5pmol) in HEK293 cells. The same reporter, when co-transfected with let-7, shows no significant change in expression levels. Luciferase reporters bearing the CREB UTR with a 2nt mutation in the miR-124 binding site (mutated CREB UTR), and a truncated CREB UTR that is missing the entire miR-124 binding site (truncated CREB UTR) are not significantly affected by co-transfection with miR-124 duplexes. An siRNA directed against the luciferase firefly gene (luc siRNA), a positive control, was able to repress all constructs containing the firefly gene by 80%. Each data point is expressed as a ratio of renilla to firefly activity, normalized to the change in luciferase activity when plasmids are transfected alone without miR duplexes. Data is shown as a mean of 8 independent trials ± S.D.
D. Fold increase in transcript levels of CREB1, KHC, UCH, and C/EBP after inhibition of miR-124, as detected by real time reverse-transcription PCR. Proteins downstream to CREB (KHC, UCH, and C/EBP) have significantly increased transcript levels, whereas a transcript not known to be an immediate early gene of CREB, neurexin shows no such increase. Transcript levels were normalized to GAPDH and data is presented as a mean of 5 independent trials ± S.D.
E. Bar graph showing the average percentage synaptic facilitation measured at 24 hrs after treatment with a single pulse of serotonin in cultures that had been pre-incubated with either the penetratin-conjugated miR-124 inhibitor or the control miR-194 inhibitor, as well as of untreated controls. The observed differences in the facilitation between the different groups were not due to differences in the basal strength of the synaptic connections as tested before 5HT application.